levetiracetam
Generic: levetiracetam in sodium chloride
Labeler: eugia us llcDrug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam in sodium chloride
Labeler
eugia us llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
levetiracetam 1500 mg/100mL
Manufacturer
Identifiers & Regulatory
Product NDC
55150-248
Product ID
55150-248_2e0b32db-b6e3-4a68-a752-e4923f4bd84a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207160
Listing Expiration
2026-12-31
Marketing Start
2017-01-04
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55150248
Hyphenated Format
55150-248
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam in sodium chloride (source: ndc)
Application Number
ANDA207160 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1500 mg/100mL
Packaging
- 10 POUCH in 1 CARTON (55150-248-47) / 1 BAG in 1 POUCH / 100 mL in 1 BAG
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2e0b32db-b6e3-4a68-a752-e4923f4bd84a", "openfda": {"nui": ["N0000008486"], "upc": ["0355150248476"], "unii": ["44YRR34555"], "rxcui": ["1193358", "1193360", "1193362"], "spl_set_id": ["e5eb4c89-8ee9-4474-9cb1-c3b3dc262a4a"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 POUCH in 1 CARTON (55150-248-47) / 1 BAG in 1 POUCH / 100 mL in 1 BAG", "package_ndc": "55150-248-47", "marketing_start_date": "20170104"}], "brand_name": "Levetiracetam", "product_id": "55150-248_2e0b32db-b6e3-4a68-a752-e4923f4bd84a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "55150-248", "generic_name": "Levetiracetam in sodium chloride", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "1500 mg/100mL"}], "application_number": "ANDA207160", "marketing_category": "ANDA", "marketing_start_date": "20170104", "listing_expiration_date": "20261231"}